Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention

Chinese Medical Journal

Volumn 124, Issue 14, 2011, Pages 2101-2106

  Li, Xi Ming ^a,b   Cong, Hong Liang ^b   Li, Ting Ting ^b   He, Li Jun ^b   Zhou, Yu Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme inhibitors; Contrast induced acute kidney injury; Percutaneous coronary intervention

Indexed keywords

BENAZEPRIL; CREATININE; NITROGEN; UREA;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RENAL PROTECTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; AGED; ANGIOPLASTY, BALLOON, CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZAZEPINES; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY;

EID: 79960658155     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.14.004     Document Type: Article

References (37)

1. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for preventing of contrast-induced nephropathy in diabetic patients: a randomized study. Indian Heart J 1999; 51: 521-526.
2. Hashemi M, Kharazi A, Shahidi S. Captopril for prevention of contrast induced nephropathy in patients undergoing coronary angioplasty: a double blind placebo controlled clinical trial. JRMS 2005; 10: 305-308.
3. Toprak O, Cirit M, Bayata S, Yeşil M, Aslan SL. The effect of pre-procedural captopril on contrast media induced nephropathy who underwent coronary angiography. Anadolu Kardiyol Derg 2003; 3: 98-103.
4. Cirit M, Toprak O, Yesil M, Bayata S, Postaci N, Pupim L, et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Practice 2006; 104: c20-c27.
5. Kiski D, Stepper W, Brand E, Breithardt G, Reinecke H. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant 2010; 25: 759-764.
6. Rosenstock JL, Bruno R, Kim JK, Lubarsky L, Schaller R, Panagopoulos G, et al. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol 2008; 40: 749-755.
7. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material linduced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149.
8. Liu DG, Wang TM. Role of connective tissue growth factor in experimental radiation nephropathy in rats. Chin Med J 2008; 121: 1925-1931.
9. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428.
10. Mehran R. Contrast-induced nephropathy remains a serious complication of PCI. J Interv Cardiol 2007; 20: 236-240.
11. Gupta R, Binbaum Y, Uretsky BF. The renal patient with coronary artery disease. Current concepts and dilemmas. J Am Coll Cardiol 2004; 44: 1343-1353.
12. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin 2005; 21: 261-280.
13. Herts BR, Schneider E, Obuchowski N, Poggio E, Jain A, Baker ME. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate. Am J Roentgenol 2009; 193: 494-500.
14. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006; 98 (6A): 14K-20K.
15. Ray S, Dutta A. Contrast-induced nephropathy. Indian Heart J 2008; 60: 133-138.
16. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116: 263-272.
17. Fleming I, Kohlstedt K, Busse R. New fACEs to the renin-angiotensin system. J Appl Physiol 2005; 20: 91-95.
18. Munzel T, Keaney JF Jr. Are ACE inhibitors a 'magic bullet' against oxidative stress? Circulation 2001; 104: 1571-1574.
19. Xu H, Chen LM, Li XW. Risk factors and prognosis of contrast induced nephropathy with renal dysfunction. Acta Acad Med Sin (Chin) 2005; 27: 232-236.
20. Erley CM. Does hydration prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant 1999; 14: 1064-1066.
21. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420.
22. Krusová D, Sevela K, Králová D, Zák P, Olovská V. Risky medication and contrast media-induced nephropathy in patients with diabetes and hypertension. Vnitr Lek 2006; 52: 1014-1020.
23. Toprak O. Letter to the editor: Angiotensin converting enzyme inhibitors and contrast-induced nephropathy. Ren Fail 2006; 28: 99-100.
24. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160: 685-693.
25. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 2002; 347: 1256-1261.
26. Mahajan S, Tiwari S, Bhowmik D, Agarwal SK, Tiwari SC, Dash SC. Factors affecting the outcome of acute renal failure among the elderly population in India: a hospital based study. Int Urol Nephrol 2006; 38: 391-396.
27. Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. Am J Cardiol 2003; 91: 1157-1162.
28. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763-1771.
29. Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004; 79: 211-219.
30. McCullough PA, Dandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003; 4 Suppl 5: S3-S9.
31. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 13-19.
32. Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv 2008; 71: 62-72.
33. Hardiek KJ, Katholi RE, Robbs RS, Katholi CE. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diabetes Complications 2008; 22: 171-177.
34. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
35. Harkonen S, Kjellstrand CM. Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med 1977; 63: 939-946.
36. Caldicott WJ, Hollenberg NK, Abrams HL. Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970; 5: 539-547.
37. Brezis M, Greenfeld Z, Shina A, Rosen S. Angiotensin II augments medullary hypoxia and predisposes to acute renal failure. Eur J Clin Invest 1990; 20: 199-207.